Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD

NCT01959516 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: Glycopyrronium
DRUG: Tiotropium
DRUG: Placebo to glycopyrronium
DRUG: Placebo to tiotropium

Sponsor

Novartis Pharmaceuticals